These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9027769)

  • 21. [Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure].
    Stoffel MP; Lauterbach KW; Baldamus CA
    Z Arztl Fortbild Qualitatssich; 2004 Oct; 98(7):609-16. PubMed ID: 15595603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis status in China: a report from the Shanghai Dialysis Registry (2000-2005).
    Yao Q; Zhang W; Qian J
    Ethn Dis; 2009; 19(1 Suppl 1):S1-23-6. PubMed ID: 19484870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dialysis an the elderly].
    Huisman RM
    Ned Tijdschr Geneeskd; 1997 Feb; 141(5):229-33. PubMed ID: 9064539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
    Hattori S; Yosioka K; Honda M; Ito H;
    Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal replacement therapy in Iran.
    Mahdavi-Mazdeh M; Heidary Rouchi A; Norouzi S; Aghighi M; Rajolani H; Ahrabi S
    Urol J; 2007; 4(2):66-70. PubMed ID: 17701924
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe.
    Viklicky O; Pokorna E; Vitko S;
    Nephrol Dial Transplant; 2006 Jul; 21(7):2025-6; author reply 2026. PubMed ID: 16735390
    [No Abstract]   [Full Text] [Related]  

  • 29. A healthier picture for dialysis patients.
    Nephrol News Issues; 1999 Sep; 13(9):15-8. PubMed ID: 10776248
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of cadaveric renal transplantation on survival in patients listed for transplantation.
    Oniscu GC; Brown H; Forsythe JL
    J Am Soc Nephrol; 2005 Jun; 16(6):1859-65. PubMed ID: 15857921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has the rise in the incidence of renal replacement therapy in developed countries come to an end?
    Jager KJ; van Dijk PC
    Nephrol Dial Transplant; 2007 Mar; 22(3):678-80. PubMed ID: 17314211
    [No Abstract]   [Full Text] [Related]  

  • 32. Modelling discrete time survival data with random slopes: evaluating haemodialysis centres.
    Carvalho MS; Knorr-Held L
    Stat Med; 2003 Nov; 22(22):3543-55. PubMed ID: 14601018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and validation of a model to predict early mortality in haemodialysis patients.
    Mauri JM; Clèries M; Vela E;
    Nephrol Dial Transplant; 2008 May; 23(5):1690-6. PubMed ID: 18272779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of integrated replacement therapy in patients with terminal renal insufficiency: selection vs election].
    Lampreabe I; Muñiz ML; Zárraga S; Amenábar JJ; Erauzkin GG; Gómez-Ullate P; Gaínza FJ
    Nefrologia; 2001; 21 Suppl 5():4-13. PubMed ID: 11881412
    [No Abstract]   [Full Text] [Related]  

  • 35. Initiation of dialysis: is the problem solved by NECOSAD?
    Korevaar JC; Dekker FW; Krediet RT
    Nephrol Dial Transplant; 2003 Jun; 18(6):1228-9; author reply 1229-30. PubMed ID: 12748363
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methods used in the treatment in chronic renal insufficiency in Andalucia: II. Local and temporal differences].
    Gentil MA; Rivas A; Muñoz J; López J; García-Valdecasas J; Soriano C; Tejuca F; Pérez Bañasco V; Alonso M; Campos T
    Nefrologia; 2000; 20 Suppl 5():70-6. PubMed ID: 11190111
    [No Abstract]   [Full Text] [Related]  

  • 37. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
    Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
    Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual Network/HCFA Report on clinical indicators shows more patients getting better care. But catheter use is up, serum albumin shows little change.
    Neumann ME
    Nephrol News Issues; 2001 May; 15(6):45-7. PubMed ID: 12109001
    [No Abstract]   [Full Text] [Related]  

  • 39. [Replacement treatment of chronic renal insufficiency. Current perspectives].
    Ortuño Mirete J
    Rev Clin Esp; 1997 May; 197(5):306-16. PubMed ID: 9280963
    [No Abstract]   [Full Text] [Related]  

  • 40. A Fresenius view of the future of ESRD care.
    Lipps B
    Nephrol News Issues; 1999 Mar; 13(3):38-9. PubMed ID: 10382487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.